Stockholders’ Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 14, 2021 |
Aug. 10, 2021 |
Jul. 14, 2021 |
Jan. 06, 2021 |
Sep. 17, 2021 |
Jun. 01, 2021 |
Feb. 28, 2021 |
May 31, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Jul. 31, 2021 |
|
Stockholders’ Equity (Textual) | ||||||||||||||
Common stock per share (in Dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||
Convertible Preferred Stock Shares Issued (in Shares) | 65,953 | |||||||||||||
(in Shares) | 25,062 | |||||||||||||
Warrants to purchase common stock, description | On January 6, 2021, The Company issued 72,369 shares of common stock and 90,461 5 year warrants to purchase shares of common stock at $4.00 per share pursuant to the prior receipt of $275,000 in equity financing. | |||||||||||||
Common shares issued (in Shares) | 298,883 | 11,060,656 | 11,060,656 | 9,895,600 | ||||||||||
Common stock placement (in Shares) | 298,883 | |||||||||||||
Warrant additional | 5 years | |||||||||||||
Warrant to purchase price | $ 1.79 | |||||||||||||
Aggregate gross proceeds | $ 525,000 | |||||||||||||
Common stock shares issued | $ 27,403 | $ 5,458 | $ 29,025 | $ 96,757 | $ 191,078 | $ 847,200 | $ 323,635 | $ 2,605,390 | ||||||
Accounts payable | $ 132,557 | |||||||||||||
Fair value price per share (in Dollars per share) | $ 2.26 | $ 2.55 | $ 2.95 | $ 1.37 | ||||||||||
Accounts payable | $ 61,930 | $ 13,919 | $ 85,622 | |||||||||||
Common stock shares issued | 11,611 | |||||||||||||
Accounts payable | $ 29,607 | |||||||||||||
Fair value price per share (in Dollars per share) | $ 2.55 | |||||||||||||
Stockholders’ equity description | the Company received $515,000 of a committed $565,000 from the sale of 135,527 shares of common stock (at a price of $3.80 per share) and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of September 30, 2021, the full amount has not been received and only $415,000 worth of the shares and warrants have been issued. The remaining $125,000 is included in equity financing within current liabilities on the consolidated balance sheet. | |||||||||||||
Unrecognized expense | $ 1,700,000 | $ 2,500,000 | ||||||||||||
Vested Restricted Stock Units [Member] | ||||||||||||||
Stockholders’ Equity (Textual) | ||||||||||||||
Stock conversion, description | Between January 25, 2021 and August 13, 2021, the company issued a total of 504,965 shares of common stock to holders of fully vested restricted stock units. | |||||||||||||
Maximum [Member] | ||||||||||||||
Stockholders’ Equity (Textual) | ||||||||||||||
Unrecognized expenses to be recognized, term | 4 years | |||||||||||||
Minimum [Member] | ||||||||||||||
Stockholders’ Equity (Textual) | ||||||||||||||
Unrecognized expenses to be recognized, term | 3 years | |||||||||||||
Common Stock [Member] | ||||||||||||||
Stockholders’ Equity (Textual) | ||||||||||||||
Common stock, shares authorized (in Shares) | 45,000,000 | 45,000,000 | ||||||||||||
Common stock shares issued | $ 73 | $ 157 | $ 170 | $ 442 | ||||||||||
Series A Convertible Preferred Stock [Member] | ||||||||||||||
Stockholders’ Equity (Textual) | ||||||||||||||
Preferred stock, shares authorized (in Shares) | 900,000 | 900,000 | ||||||||||||
Stock conversion, description | During February 2021, the Company issued 52,632 shares of common stock to a holder of its Series A Convertible Preferred Stock upon the conversion of 20,000 of such shares of Series A Convertible Preferred Stock. |